跳至主要内容
临床试验/NCT03513432
NCT03513432已完成不适用

Influence of Beer on Gut Microbiota and Biochemical Outcomes: Alcohol Impact.

Universidade do Porto2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年3月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
2
主要终点
Changes in intestinal microbiota from baseline

研究概览

简要总结

Our aim is to assess the effects of moderate consumption of beer and non-alcoholic beer on gut microbiota and biochemical biomarkers in healthy adults.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Adult men (18-65 years);
  • Healthy volunteers free of chronic diseases with relevant effect on gastrointestinal system;
  • Without a diagnosis of any digestive disease including functional bowel disorders such as IBS;
  • Moderate alcohol consumers;
  • Willing and able to provide written informed consent.

排除标准

  • Documented cardiovascular disease (ischaemic heart disease - angina or recent or old myocardial infarction or previous or cerebral vascular accident, peripheral vascular disease);
  • With diabetes or other relevant metabolic diseases;
  • With any known infectious diseases, namely infections with HIV, Hepatitis B or C virus;
  • Intake of antibiotics in the last 4 weeks and laxatives in the last 2 weeks;
  • Subjects with history of drug, alcohol or other substances abuse.

结局指标

主要结局

Changes in intestinal microbiota from baseline

时间窗: at visit 1 (after 1-week run-in period) and at visit 2 (after 4-week intake period)

次要结局

  • Changes in fasting serum triglycerides from baseline(at visit 1 (after 1-week run-in period) and at visit 2 (after 4-week intake period))
  • Changes in fasting serum cHDL from baseline(at visit 1 (after 1-week run-in period) and at visit 2 (after 4-week intake period))
  • Changes in Homeostasis Model Assessment-Insulin Resistance (HOMA-IR) from baseline(at visit 1 (after 1-week run-in period) and at visit 2 (after 4-week intake period))
  • Changes in fasting serum total cholesterol from baseline(at visit 1 (after 1-week run-in period) and at visit 2 (after 4-week intake period))
  • Changes in fasting serum cLDL from baseline(at visit 1 (after 1-week run-in period) and at visit 2 (after 4-week intake period))
  • Changes in fasting serum LPS levels from baseline(at visit 1 (after 1-week run-in period) and at visit 2 (after 4-week intake period))
  • Changes in body mass index from baseline(at visit 1 (after 1-week run-in period) and at visit 2 (after 4-week intake period))
  • Changes in total body fat mass from baseline(at visit 1 (after 1-week run-in period) and at visit 2 (after 4-week intake period))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验